title: Fatherhood during imatinib.
authors.forename: Emad
authors.initials: E
authors.lastname: Shash
authors.forename: Simona
authors.initials: S
authors.lastname: Bassi
authors.forename: Emilia
authors.initials: E
authors.lastname: Cocorocchio
authors.forename: Giovanni Maria
authors.initials: GM
authors.lastname: Colpi
authors.forename: Saverio
authors.initials: S
authors.lastname: Cinieri
authors.forename: Fedro Alessandro
authors.initials: FA
authors.lastname: Peccatori
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D005220:Fathers; D005260:Female; D005298:Fertility / Q000187:drug effects / Q000502:physiology; D006801:Humans; D000068877:Imatinib Mesylate; D007231:Infant, Newborn; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy / Q000534:rehabilitation; D011256:Pregnancy Outcome; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate